April 26, 2017 / 8:42 AM / 4 months ago

BRIEF-Guizhou Xinbang Pharmaceutical sees H1 2017 net profit up 5-20 pct

April 26 (Reuters) - Guizhou Xinbang Pharmaceutical Co Ltd :

* Sees net profit for H1 2017 to increase by 5 percent to 20 percent, or to be 136.5 million yuan to 156.0 million yuan, compared to net profit of the same period in 2016 (130.0 million yuan)

* Comments that increased sales of medical logistic, service and industry business is the main reason for the forecast

Source text in Chinese: goo.gl/aTTh47

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below